Suppr超能文献

[关于血清中α-胰蛋白酶抑制剂的降解产物。I. α-胰蛋白酶抑制剂作为血清中酸稳定的胰蛋白酶-纤溶酶抑制剂的前体(作者译)]

[About degradation products of the inter-alpha-trypsin inhibitor in serum. I. The inter-alpha-trypsin inhibitor as precursor of the acid stable trypsin-plasmin-inhibitor of the serum (author's transl)].

作者信息

Hochstrasser K, Niebel J, Feuth H, Lempart K

出版信息

Klin Wochenschr. 1977 Apr 1;55(7):337-42. doi: 10.1007/BF01488112.

Abstract

The humoral inter-alpha-trypsin inhibitor is to define as precursor of the acid stable trypsin-plasmin-inhibitor in the serum. The inhibitor is filtrated by the glomerulum and excreted in the urine. The serum level of the inhibitor is increased in nephropathy. Using a new assay for the intact precursor it was found that during inflammation the decreased precursor level indicates an increased turnover, though the glomerular filtration of the acid-stable inhibitor is within normal range. The increase of the precursor level during nephropathy indicates that the kidney is the main degradation organe for the inter-alpha-trypsin inhibitor. Nevertheless, an increase of the acid-stable inhibitor is to be seen. This fact is only to explain if it is assumed that the inter-alpha-trypsin inhibitor is permanently degraded everywhere in the organism.

摘要

体液中的α-胰蛋白酶抑制剂被定义为血清中酸稳定的胰蛋白酶-纤溶酶抑制剂的前体。该抑制剂经肾小球滤过并随尿液排出。在肾病中,该抑制剂的血清水平会升高。使用一种针对完整前体的新检测方法发现,在炎症期间,前体水平降低表明其周转率增加,尽管酸稳定抑制剂的肾小球滤过在正常范围内。肾病期间前体水平的升高表明肾脏是α-胰蛋白酶抑制剂的主要降解器官。然而,仍可观察到酸稳定抑制剂的增加。只有假设α-胰蛋白酶抑制剂在机体各处持续降解,才能解释这一事实。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验